MPLT
Financials
- Market Capitalization 584.36 M
- Employee 133
- Founded 2018
- CEO N/A
- Website www.maplightrx.com
- Headquarter Delaware, United States
- FIGI BBG01JZ5DBQ0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2808 |  ARVN Arvinas, Inc. - Common Stock | 9.18 USD | -0.65% | -2.13% | +13.19% | -1.29% | 600.25 M USD | ||
| 2830 |  SPRY ARS Pharmaceuticals, Inc. - Common Stock | 5.89 USD | -2.32% | +9.07% | +1.55% | -36.05% | 585.74 M USD | ||
| 2855 |  VALN Valneva SE - American Depositary Shares | 6.43 USD | -2.28% | -3.74% | +27.08% | -20.22% | 557.93 M USD | ||
| 2856 |  CAPR Capricor Therapeutics, Inc. - Common Stock | 9.59 USD | -4.67% | +19.58% | +212.38% | +53.19% | 557.55 M USD |
Frequently asked questions about MapLight Therapeutics, Inc. Common Stock
What is the MapLight Therapeutics, Inc. Common Stock stock price today?
The current price of MapLight Therapeutics, Inc. Common Stock (MPLT) is 12.60. Over the past 24 hours, the stock has changed by +0.48%. Follow the MPLT chart for real-time price dynamics.
What is the stock ticker of MapLight Therapeutics, Inc. Common Stock?
MapLight Therapeutics, Inc. Common Stock trades under the ticker MPLT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is MapLight Therapeutics, Inc. Common Stock stock going up?
MPLT has changed by +12.40% over the last week, -16.94% over the last month, and -33.68% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of MapLight Therapeutics, Inc. Common Stock?
MapLight Therapeutics, Inc. Common Stock currently has a market capitalization of 584.36 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were MapLight Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, MapLight Therapeutics, Inc. Common Stock reported earnings of -1.32 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was MapLight Therapeutics, Inc. Common Stock revenue for the last quarter?
MapLight Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was MapLight Therapeutics, Inc. Common Stock net income for the last quarter?
MapLight Therapeutics, Inc. Common Stock reported net income of -60.19 M for the last quarter. The previous quarter showed -60.67 M, which means net income changed by +0.78%.
How many employees does MapLight Therapeutics, Inc. Common Stock have?
As of the latest available data, MapLight Therapeutics, Inc. Common Stock has 133 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy MapLight Therapeutics, Inc. Common Stock stock?
You can buy MapLight Therapeutics, Inc. Common Stock (MPLT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in MapLight Therapeutics, Inc. Common Stock stock?
Investing in MapLight Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MPLT chart and related analysis on metatrader.com as part of your research.